The association of biochemical and genetic biomarkers in VEGF pathway with depression (2022)
- Authors:
- USP affiliated authors: PINHEIRO, LUCAS CÉZAR - EERP ; BAES, CRISTIANE VON WERNE - FMRP ; LACCHINI, FERNANDA BORCHERS COELI - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP ; JURUENA, MÁRIO FRANCISCO PEREIRA - EERP ; LACCHINI, RICCARDO - EERP ; NUNES, FERNANDA DANIELA DORNELAS - EERP
- Unidades: EERP; FMRP
- DOI: 10.3390/pharmaceutics14122757
- Subjects: DEPRESSÃO; COMPORTAMENTO DE RISCO; SUICIDAS; POLIMORFISMO
- Keywords: KDR; VEGF; Depression; Polymorphism; s-FLT; Suicidal behavior
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Pharmaceutics
- ISSN: 1999-4923
- Volume/Número/Paginação/Ano: v. 14, n. 12, art. 2757, p. 1-15, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
NUNES, Fernanda Daniela Dornelas et al. The association of biochemical and genetic biomarkers in VEGF pathway with depression. Pharmaceutics, v. 14, n. 12, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics14122757. Acesso em: 30 maio 2024. -
APA
Nunes, F. D. D., Ferezin, L. P., Pereira, S. C., Figaro-Drumond, F. V., Pinheiro, L. C., Menezes, I. C., et al. (2022). The association of biochemical and genetic biomarkers in VEGF pathway with depression. Pharmaceutics, 14( 12), 1-15. doi:10.3390/pharmaceutics14122757 -
NLM
Nunes FDD, Ferezin LP, Pereira SC, Figaro-Drumond FV, Pinheiro LC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Tanus-Santos JE, Juruena MF, Lacchini R. The association of biochemical and genetic biomarkers in VEGF pathway with depression [Internet]. Pharmaceutics. 2022 ; 14( 12): 1-15.[citado 2024 maio 30 ] Available from: https://doi.org/10.3390/pharmaceutics14122757 -
Vancouver
Nunes FDD, Ferezin LP, Pereira SC, Figaro-Drumond FV, Pinheiro LC, Menezes IC, Baes CVW, Coeli-Lacchini FB, Tanus-Santos JE, Juruena MF, Lacchini R. The association of biochemical and genetic biomarkers in VEGF pathway with depression [Internet]. Pharmaceutics. 2022 ; 14( 12): 1-15.[citado 2024 maio 30 ] Available from: https://doi.org/10.3390/pharmaceutics14122757 - Empoderamento do enfermeiro por meio da Farmacogenética
- Genetic biomarkers for differential diagnosis of major depressive disorder and bipolar disorder: a systematic and critical review
- Association of 11β-hydroxysteroid dehydrogenase type1 (HSD11b1) gene polymorphisms with outcome of antidepressant therapy and suicide attempts
- Circulating HO-1 levels are not associated with plasma sFLT-1 and GTn HMOX1 polymorphism in preeclampsia
- Endothelial nitric oxide synthase polymorphisms affect the changes in blood pressure and nitric oxide bioavailability induced by propofol
- Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence
- Increased activity of MMP-2 in hypertensive obese children is associated with hypoadiponectinemia
- Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases
- Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease
- Endothelial nitric oxide synthase: from biochemistry and gene structure to clinical implications of NOS3 polymorphisms
Informações sobre o DOI: 10.3390/pharmaceutics14122757 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003155276.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
